CompanyGraph
Oncoclínicas do Brasil Serviços Médicos S.A.
ONCO3 · Brazil
grupooncoclinicas.comFinancials as of FY2025
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $186.29M, lower than 95% of all stocks globally
- PositionOperating margin is -24.3%, lower than 95% of its Medical Care Facilities peers (median 11%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
954.23MBRL186.29M · vs all stocks (USD)
Revenue (TTM)
5.41BBRL1.06B · vs all stocks (USD)
Profit Margin
-71.05%vs Medical Care Facilities peers
Beta
0.8870xvs all stocks
52-Week Change
-84.46%vs all stocks
Market Capitalization
954.23MBRL186.29M · vs all stocks (USD)
Enterprise Value
4.89BBRL954.51M · vs all stocks (USD)
Forward P/E
12.19xvs Medical Care Facilities peers
Price to Sales (TTM)
0.1993xvs Medical Care Facilities peers
Price to Book (MRQ)
2.01xvs Medical Care Facilities peers
Enterprise to Revenue
0.9040xvs Medical Care Facilities peers
Enterprise to EBITDA
-3.22xvs Medical Care Facilities peers
Gross Margin
17.18%vs Medical Care Facilities peers
Profit Margin
-71.05%vs Medical Care Facilities peers
Operating Margin
-24.26%vs Medical Care Facilities peers
Return on Assets (TTM)
-12.04%vs Medical Care Facilities peers
Return on Equity (TTM)
-205.90%vs Medical Care Facilities peers
Revenue (TTM)
5.41BBRL1.06B · vs all stocks (USD)
Revenue per Share (TTM)
5.77BRLUpdated Jul 17, 2026Quarterly Revenue Growth
-22.30%vs Medical Care Facilities peers
Gross Profit (TTM)
1.57BBRL307.20M · vs all stocks (USD)
EBITDA (TTM)
-1.52BBRL-296.61M · vs all stocks (USD)
Net Income (TTM)
-3.84BBRL-749.98M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-22.26%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
-260.80MBRL-50.92M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-670.35MBRL-130.87M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00BRLUpdated Jul 17, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
161.48MBRLFY2025 · Dec 31, 2025Revenue
5.74BBRLFY2025 · Dec 31, 2025Cost of Goods Sold
3.95BBRLFY2025 · Dec 31, 2025Gross Profit
1.79BBRLFY2025 · Dec 31, 2025Operating Income
-2.47BBRL-481.54M · vs all stocks (USD)
Pre-tax Income
-3.16BBRLFY2025 · Dec 31, 2025Income Tax Expense
508.46MBRLFY2025 · Dec 31, 2025Net Income
-3.67BBRLFY2025 · Dec 31, 2025EBIT
-2.53BBRLFY2025 · Dec 31, 2025EBITDA (Income Statement)
-2.15BBRLFY2025 · Dec 31, 2025Selling, General & Administrative
1.36BBRLFY2025 · Dec 31, 2025Other Operating Expenses
2.89BBRLFY2025 · Dec 31, 2025Non-operating Interest Income
13.12MBRLFY2025 · Dec 31, 2025Non-operating Interest Expense
636.27MBRLFY2025 · Dec 31, 2025EPS (Basic)
-4.18BRLFY2025 · Dec 31, 2025EPS (Diluted)
-4.18BRLFY2025 · Dec 31, 2025Basic Shares Outstanding
866.52MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
866.52MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-3.67BBRLFY2025 · Dec 31, 2025Minority Interests (P&L)
47.32MBRLFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025Operating Cash Flow
-2.06BBRLFY2025 · Dec 31, 2025Free Cash Flow
-2.23BBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
509.55MBRLFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-3.67BBRLFY2025 · Dec 31, 2025Stock-based Compensation
22.18MBRLFY2025 · Dec 31, 2025Other Non-cash Items
1.81BBRLFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-319.26MBRLFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
103.08MBRLFY2025 · Dec 31, 2025Capital Expenditures
-168.12MBRLFY2025 · Dec 31, 2025Net Acquisitions
-76.74MBRLFY2025 · Dec 31, 2025Other Investing Activity
5.76MBRLFY2025 · Dec 31, 2025Net Investing Cash Flow
-239.09MBRLFY2025 · Dec 31, 2025Long-term Debt Issuance
310.12MBRLFY2025 · Dec 31, 2025Long-term Debt Payments
-735.06MBRLFY2025 · Dec 31, 2025Common Stock Repurchase
-3.69MBRLFY2025 · Dec 31, 2025Common Dividends Paid
-36.78MBRLFY2025 · Dec 31, 2025Other Financing Charges
-26.60MBRLFY2025 · Dec 31, 2025Net Financing Cash Flow
-490.92MBRLFY2025 · Dec 31, 2025Shares Outstanding
1.12BSharesUpdated Jul 17, 2026Float Shares
447.23MSharesUpdated Jul 17, 2026% Held by Insiders
18.62%vs all stocks
% Held by Institutions
78.80%vs all stocks
Total Cash (MRQ)
112.29MBRL21.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1000BRLUpdated Jul 17, 2026Total Debt (MRQ)
3.84BBRL749.74M · vs all stocks (USD)
Total Debt to Equity (MRQ)
6.18xvs Medical Care Facilities peers
Current Ratio (MRQ)
0.4620xvs Medical Care Facilities peers
Book Value per Share (MRQ)
0.4770BRLUpdated Jul 17, 2026Total Assets
7.13BBRL1.39B · vs all stocks (USD)
Total Current Assets
2.90BBRLFY2025 · Dec 31, 2025Total Liabilities
6.07BBRLFY2025 · Dec 31, 2025Total Non-current Assets
4.23BBRLFY2025 · Dec 31, 2025Total Non-current Liabilities
866.17MBRLFY2025 · Dec 31, 2025Total Current Liabilities
5.20BBRLFY2025 · Dec 31, 2025Cash
35.90MBRLFY2025 · Dec 31, 2025Cash Equivalents
473.64MBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents
509.55MBRLFY2025 · Dec 31, 2025Other Short-term Investments
736.00KBRLFY2025 · Dec 31, 2025Accounts Receivable
2.03BBRLFY2025 · Dec 31, 2025Inventory
185.48MBRLFY2025 · Dec 31, 2025Accounts Payable
1.10BBRLFY2025 · Dec 31, 2025Short-term Debt
3.22BBRLFY2025 · Dec 31, 2025Other Current Liabilities
157.72MBRLFY2025 · Dec 31, 2025Long-term Debt
574.32MBRLFY2025 · Dec 31, 2025Other Non-current Liabilities
67.53MBRLFY2025 · Dec 31, 2025Common Stock (Book)
4.56BBRLFY2025 · Dec 31, 2025Retained Earnings
-4.33BBRLFY2025 · Dec 31, 2025Total Shareholders' Equity
1.06BBRL207.41M · vs all stocks (USD)
Treasury Stock
87.57MBRLFY2025 · Dec 31, 202552-Week Low
0.6300BRLUpdated Jul 17, 202652-Week High
6.00BRLUpdated Jul 17, 202652-Week Change
-84.46%vs all stocks
Beta
0.8870xvs all stocks
50-Day MA
1.26BRLUpdated Jul 17, 2026200-Day MA
1.95BRLUpdated Jul 17, 2026Avg 10-Day Volume
15.72MSharesUpdated Jul 17, 2026Avg 30-Day Volume
9.94MSharesUpdated Jul 17, 2026Diluted EPS (TTM)
-4.34BRLUpdated Jul 17, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -24.3%, lower than 95% of its Medical Care Facilities peers (median 11%)Significant
Operating margin: -0.24Industry median: 0.11Industry P5: -0.02Peers compared: 70.00
Profit margin is -71%, lower than 95% of its Medical Care Facilities peers (median 8.1%)Significant
Profit margin: -0.71Industry median: 0.08Industry P5: -0.06Peers compared: 70.00
Return on equity is -205.9%, lower than 95% of its Medical Care Facilities peers (median 10.7%)Significant
Return on equity: -2.06Industry median: 0.11Industry P5: -0.13Peers compared: 70.00
Return on assets is -12%, lower than 95% of its Medical Care Facilities peers (median 5.6%)Significant
Return on assets: -0.12Industry median: 0.06Industry P5: -0.06Peers compared: 70.00
Current ratio is 0.46×, lower than 95% of its Medical Care Facilities peers (median 1.57×)Significant
Current ratio: 0.46Industry median: 1.57Industry P5: 0.64Peers compared: 70.00
Debt-to-equity is 6.18×, higher than 95% of its Medical Care Facilities peers (median 0.38×)Significant
Debt-to-equity: 6.18Industry median: 0.38Industry P95: 2.24Peers compared: 70.00
Financial Health
Altman Z-Score -1.51: distress zoneCritical
Altman Z-Score: -1.51
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $186.29M, lower than 95% of all stocks globallySignificant
Market cap (USD): 186,293,440.07Global P5: 269,387,740.27
Revenue is $1.06B, above the global median of $520.53MNotable
Revenue (USD): 1,055,605,123.973Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Hyundai Corporation
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Seacor Marine Holdings Inc.
Tier 1FlowThroughput-Bound ConversionProductionRisk
HwaCom Systems Inc.
Tier 1FlowThroughput-Bound ConversionRuleProduction
BayWa AG
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Shih Wei Navigation Co. Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Naturelgaz Sanayi ve Ticaret A.Ş.
Tier 1FlowThroughput-Bound ConversionProductionRule
Mitani Sangyo Co., Ltd.
Tier 1FlowThroughput-Bound ConversionProductionInterface
Meiwa Corporation
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Shanghai Material Trading Co. Ltd.
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Forcecon Technology Co., Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Neuromeka Co., Ltd.
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated